Hiv/aids - Drug Pipeline Analysis And Market Forecasts To 2016----aarkstore Enterprise

Summary

Summary

HIV/AIDS Drug Pipeline Analysis and Market Forecasts to 2016 is an essential source of information and analysis on the global HIV/AIDS market. The report identifies the key trends shaping and driving the global HIV/AIDS market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global HIV/AIDS sector. GlobalData estimated the HIV/AIDS market was worth $12 billion in 2009. The global Human Immunodeficiency Virus (HIV) infection market will continue to grow between 2009 and 2016 at a slower rate due to a series of patent expiries during this period. The growth rate is likely to decline from 2012 onwards due to the impact of the patent expiry of key drugs. The market is characterized by a high unmet need of drugs which can cure the disease. Highly Active Antiretroviral Therapy (HAART) which requires patients to take different classes of drugs has however succeeded in achieving near zero levels of HIV in infected people. Increased uptake of HAART and increasing awareness (which leads to increased treatment seeking) will drive the market. The pipeline for HIV is strong and consists of more than 250 molecules currently in development for various disease segments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalDatas team of industry experts.

Scope

- Annualized global HIV/AIDS market revenues data from 2001 to 2009, forecast for seven years to 2016.

- Geographies covered in this report are the United States (US), the United Kingdom (UK), Italy, Spain, Germany, France and Japan.

- Pipeline analysis data providing a split across phases by mechanism of action, and the emerging trends. The key classes of mechanism of action include HIV vaccines, Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs), Protease Inhibitors (PIs), Multi-class Combination Products, Nucleoside Reverse Transcriptase Inhibitors (NRTIs), CCR5 receptor antagonists, HIV integrase inhibitors, Nucleoside analogues, Viral entry inhibitors, Maturation inhibitors and Fusion Inhibitors.

- Analysis of the current and future market competition in the global HIV/AIDS market. The key market players covered Boehring Ingelheim, Achillion Pharmaceuticals, GlaxoSmithKline, Incyte and Pharmasset, Shire Pharmaceuticals and Tibotec Virco

For more information please contact :

http://www.aarkstore.com/reports/HIV-AIDS-Drug-Pipeline-Analysis-and-Market-Forecasts-to-2016-40849.html

http://blogs.aarkstore.com/

From:Aarkstore Enterprise

Contact: Neel

Email: press@aarkstore.com

URL: www.aarkstore.com

by: Aarkstore

POST COMMENT

Men's Grooming Products: A Global Analysis-aarkstore Enterprise Market Research Aggregator Good Affiliate Marketing Tools Especially Wealthy Affiliate Tools Will Make You Money Nonalcoholic Steatohepatitis - Drug Pipeline Analysis And Market Forecasts To 2016 Global Drug Eluting Balloons (deb) Pipeline Analysis, Opportunity Assessment And Market Forecasts To Make Profit from Buying and Selling Domain Names -plr articles Barnes & Noble Inc. - Swot Analysis - Market Reserach Report On Aarkstore Enterprise. Choosing the best Online Marketing Consultant Successful Article Marketing: 4 Steps To Becoming A Well Rounded Article Writer USB – Why you should consider using it for your next marketing campaign How to Commence an Net Marketing and advertising Marketing campaign The online shop is a battery supermarket for la ptop battery, camera battery Highly Effective Lead Generation Tactics Shared by a Successful Online Marketer Improve Your Profit Through Email Marketing